Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX
· Real-Time Price · USD
1.58
0.02 (1.28%)
At close: Aug 15, 2025, 3:59 PM
1.57
-0.63%
After-hours: Aug 15, 2025, 04:04 PM EDT
Repare Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 250K | n/a | n/a | 53.48M | 1.07M | 52.4M | 13.05M | 2.16M | 30.25M | 5.68M | 18.2M | 112.55M | 679K | 408K | 6.88M | 278K | 279K | 166K |
Cost of Revenue | n/a | 1.19M | 78.07M | -57K | 488K | 501K | 506K | 10.7M | 1.05M | 982K | 1.02M | 31.24M | 1.07M | 26.46M | 993K | 25.36M | 20.2M | 16.51M |
Gross Profit | 250K | -1.19M | -454K | 40.1M | 585K | 51.9M | 12.54M | -8.54M | 29.2M | 4.7M | 17.18M | 81.3M | -391K | -26.05M | 5.88M | -25.08M | -19.93M | -16.34M |
Operating Income | -17.78M | -31.19M | -30.66M | -36.37M | -37.32M | 10.82M | -30.45M | -38.42M | -12.26M | -34.68M | -19.63M | 73.4M | -38.73M | -34.83M | -28.73M | -31.68M | -26.67M | -21.58M |
Interest Income | 1.24M | 1.54M | 2.02M | 2.51M | 2.89M | 2.97M | 3.11M | 3.31M | 3.49M | 3.43M | 2.93M | 2.03M | 544K | 129K | 104K | 53K | 38K | 64K |
Pretax Income | -16.5M | -29.67M | -28.53M | -33.92M | -34.19M | 13.79M | -27.42M | -35.18M | -8.84M | -31.32M | -16.63M | 75.52M | -38.06M | -34.73M | -28.7M | -31.6M | -26.73M | -21.55M |
Net Income | -16.74M | -30.04M | -28.67M | -34.41M | -34.77M | 13.16M | -28.03M | -18.88M | -11.95M | -34.94M | -31.66M | 75.46M | -38.09M | -34.76M | -28.29M | -30.89M | -26.31M | -21.42M |
Selling & General & Admin | 6.03M | 7.65M | 6.3M | 6.44M | 8.32M | 8.62M | 8.53M | 7.87M | 8.72M | 8.53M | 7.94M | 7.9M | 7.94M | 8.78M | 7.64M | 6.6M | 6.74M | 5.24M |
Research & Development | 14.28M | 20.27M | 25.74M | 28.4M | 29.33M | 32.47M | 34.46M | 32.71M | 33.79M | 31.83M | 29.89M | 31.24M | 31.48M | 26.46M | 27.97M | 25.36M | 20.2M | 16.51M |
Other Expenses | -2.28M | 3.27M | -79.47M | 1.53M | n/a | n/a | n/a | -32.71M | -26K | -15K | 13K | -37K | -11K | -8K | -20K | -7K | -7K | -7K |
Operating Expenses | 18.03M | 31.19M | -47.42M | 36.37M | 37.64M | 41.09M | 42.99M | 7.87M | 42.51M | 40.36M | 37.83M | 39.15M | 39.41M | 35.24M | 35.61M | 31.96M | 26.95M | 21.75M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -116K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 18.03M | 31.19M | 30.65M | 36.37M | 38.13M | 41.59M | 43.5M | 40.58M | 42.51M | 40.36M | 37.83M | 39.15M | 39.41M | 35.24M | 35.61M | 31.96M | 26.95M | 21.75M |
Income Tax Expense | 248K | -370K | 140K | 485K | 586K | 629K | 606K | -16.3M | 3.11M | 3.62M | 15.03M | 54K | 33K | 32K | -412K | -708K | -421K | -137K |
Shares Outstanding (Basic) | 42.92M | 42.59M | 42.41M | 42.45M | 42.45M | 42.23M | 42.14M | 42.1M | 42.09M | 42.04M | 42.04M | 41.95M | 41.9M | 41.86M | 39.99M | 37.12M | 37.04M | 36.92M |
Shares Outstanding (Diluted) | 42.92M | 42.59M | 42.41M | 42.45M | 42.45M | 44.02M | 42.14M | 42.1M | 42.09M | 42.04M | 42.04M | 44.18M | 41.9M | 41.86M | 40.17M | 37.12M | 37.04M | 36.92M |
EPS (Basic) | -0.39 | -0.71 | -0.67 | -0.81 | -0.82 | 0.31 | -0.67 | -0.45 | -0.28 | -0.83 | -0.75 | 1.80 | -0.91 | -0.83 | -0.71 | -0.83 | -0.71 | -0.58 |
EPS (Diluted) | -0.39 | -0.71 | -0.67 | -0.81 | -0.82 | 0.30 | -0.67 | -0.45 | -0.28 | -0.83 | -0.75 | 1.71 | -0.91 | -0.83 | -0.7 | -0.83 | -0.71 | -0.58 |
EBITDA | -19.03M | -31.19M | -28.08M | -34.37M | -36.82M | 11.32M | -30.36M | -37.92M | -11.75M | -34.24M | -19.18M | 73.88M | -38.21M | -34.31M | -28.37M | -31.31M | -26.25M | -21.26M |
EBIT | -20.06M | -27.92M | -28.53M | -34.84M | -37.32M | 10.82M | -30.87M | -38.42M | -12.26M | -34.68M | -19.63M | 73.4M | -38.73M | -34.83M | -28.73M | -31.68M | -26.67M | -21.58M |
Depreciation & Amortization | 1.04M | 1.19M | 454K | 478K | 488K | 501K | 506K | 498K | 1.05M | 982K | 1.02M | 484K | 1.07M | 1.06M | 993K | 869K | 789K | 693K |